Adam Bohr, PhD is the CEO and co-founder of Sonohaler, an mhealth and medical device company focused on asthma management using acoustic signals and machine learning tools. He is also a co-founder of Zerion ApS, a pharmaceutical company aspiring to transform the pharmaceutical landscape for formulation of poorly soluble drugs. Previously, he was employed as assistant professor at the Department of Pharmacy, University of Copenhagen where he was doing research on drug implants, nanomedicine and microfluidic technology and teaching pharmaceutical technology subjects. He has published more than 45 peer reviewed academic papers and book chapters and has a PhD in Biomedical Engineering from University College London. He is a health futurist and a healthcare AI proponent with a passion for patient centered healthcare technologies. Kaveh Memarzadeh, PhD is currently a Commercial Field Application Scientist at ChemoMetec, a biotechnology company that innovates in the field of automated cell cytometry. He oversaw research management and communications at Orthopaedic Research UK (ORUK), a UK based medical charity that funds projects into the betterment and improvement of human movement and augmentation. He has published numerous peer-reviewed academic papers and has a PhD in nanotechnology, biomaterials and microbiology. He is also a visiting lecturer at University College London, teaching on a range of topics from the future of prosthetics/bionics to utilization of nanotechnology for antimicrobial bone implants. In his spare time, he reads, paints, builds his own gaming computers and utilizes the power of social media to share his passion for nature with hundreds of thousands of people.